If you miss a dose, follow product-specific instructions: For Ozempic, if more than 5 days have passed, skip that dose and take the next dose on the regularly scheduled day
Anticipated advancements in treatment personalization and technology promise to enhance the efficacy and engagement of patients in their care, ushering in a new era of diabetes management
Important safety information Certain GLP-1 therapies such as semaglutide (the active ingredient in Ozempic, Rybelsus, and Wegovy), liraglutide (the active ingredient in Saxenda and Victoza), and tirzepatide (the active ingredient in Mounjaro and Zepbound) may increase the likelihood of developing thyroid gland tumors, including MTC, a type of thyroid cancer
Side effects, if present, typically peak and then begin to subside
Factors such as the desired degree of weight loss, glycemic control goals, and cost considerations play a role in determining the most suitable treatment